Send feedback

AMDHD2 p.Glu157Lys

c.469G>A · rs368676622 · VCV3115028

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.1304 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0331%, mid)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.1304likely benign
REVEL0.617indeterminate
SaProtLLR -10.17damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 8.5GERP 1.6, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 9,101 bp · p 0.046 · regional, not allelic
Overall
CADD23.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0331% Middle Eastern · 2/6,040 alleles
Filtering AF 0.0244% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0234%
Overall 0.0219% 349/1,594,092 alleles · ultra-rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0403% 2,479
Middle Easterngrpmax 0.0331% 3,020
European (non-Finnish) 0.0269% 3,723
African / African-American 0.00401% 24,945
East Asian 0.00224% 44,740
Admixed American 0.00168% 59,650
South Asian 0.0011% 90,670

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AMDHD2
Protein
p.Glu157Lys
Coding
c.469G>A
MANE Select
NM_001330449
dbSNP
rs368676622
Type
single nucleotide variant
Location
chr16:2527826 (GRCh38)
Gene constraint
LOEUF 0.868 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 94.49 · 2 PDB
Residue 157
an α-helix
Full AMDHD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/amdhd2-p-glu157lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown